Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site

Human Molecular Genetics

Volumn 12, Issue 5, 2003, Pages 535-549

  Ulaner, Gary A ^a   Vu, Thanh H ^a   Li, Tao ^a   Hu, Ji Fan ^a   Yao, Xiao Ming ^a   Yang, Youwen ^a   Gorlick, Richard ^b   Meyers, Paul ^b   Healey, John ^b   Ladanyi, Marc ^b   Hoffman, Andrew R ^a  

^a STANFORD UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; SOMATOMEDIN B; TUMOR SUPPRESSOR PROTEIN; ZINC FINGER PROTEIN;

ALLELE; ARTICLE; BINDING SITE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOME IMPRINTING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION;

BINDING SITES; DNA METHYLATION; DNA-BINDING PROTEINS; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; OSTEOSARCOMA; REPRESSOR PROTEINS; RNA, UNTRANSLATED; TRANSCRIPTION FACTORS;

EID: 0037339969     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg034     Document Type: Article

References (43)

1. DeChiara, T.M., Efstratiadis, A. and Robertson, E.J. (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature, 345, 78-80.
2. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. and Tycko, B. (1993) Tumour-suppressor activity of H19 RNA. Nature, 365, 764-767.
3. Ohlsson, R., Nystrom, A., Pfeifer-Ohlsson, S., Tohonen, V., Hedberg, F., Schofield, P., Flam, F. and Ekstrom, T.J. (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat. Genet., 4, 94-97.
4. Zhang, Y. and Tycko, B. (1992) Monoallelic expression of the human H19 gene. Nat. Genet., 1, 40-44.
5. Rainier, S., Johnson, L.A., Dobry, C.J., Ping, A.J., Grundy, P.E. and Feinberg, A.P. (1993) Relaxation of imprinted genes in human cancer. Nature, 362, 747-749.
6. Ogawa, O., Eccles, M.R., Szeto, J., McNoe, L.A., Yun, K., Maw, M.A., Smith, P.J. and Reeve, A.E. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature, 362, 749-751.
7. Cui, H., Horon, I.L., Ohlsson, R., Hamilton, S.R. and Feinberg, A.P. (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med., 4, 1276-1280.
8. Sullivan, M.J., Taniguchi, T., Jhee, A., Kerr, N. and Reeve, A.E. (1999) Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene, 18, 7527-7534.
9. Vu, T.H., Li, T., Nguyen, D., Nguyen, B.T., Yao, X.M., Hu, J.F. and Hoffman, A.R. (2000) Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics, 64, 132-143.
10. Bell, A.C. and Felsenfeld, G. (2000) Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature, 405, 482-485.
11. Hark, A.T., Schoenherr, C.J., Katz, D.J., Ingram, R.S., Levorse, J.M. and Tilghman, S.M. (2000) CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature, 405, 486-489.
12. Szabo, P., Tang, S.H., Rentsendorj, A., Pfeifer, G.P. and Mann, J.R. (2000) Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr. Biol., 10, 607-610.
13. Kanduri, C., Pant, V., Loukinov, D., Pugacheva, E., Qi, C.F., Wolffe, A., Ohlsson, R. and Lobanenkov, V.V. (2000) Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr. Biol., 10, 853-856.
14. Zhang, Y., Shields, T., Crenshaw, T., Hao, Y., Moulton, T. and Tycko, B. (1993) Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet., 53, 113-124.
15. Jinno, Y., Sengoku, K., Nakao, M., Tamate, K., Miyamoto, T., Matsuzaka, T., Sutcliffe, J.S., Anan, T., Takuma, N., Nishiwaki, K. et al. (1996) Mouse/ human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum. Mol. Genet., 5, 1155-1161.
16. Takai, D., Gonzales, F.A., Tsai, Y.C., Thayer, M.J. and Jones, P.A. (2001) Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet., 10, 2619-2626.
17. Cui, H., Niemitz, E.L., Ravenel, J.D., Onyango, P., Brandenburg, S.A., Lobanenkov, V.V. and Feinberg, A.P. (2001) Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res., 61, 4947-4950.
18. Nakagawa, H., Chadwick, R.B., Peltomaki, P., Plass, C., Nakamura, Y. and de La Chapelle, A. (2001) Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl Acad. Sci. USA, 98, 591-596.
19. Feinberg, A.P., Cui, H. and Ohlsson, R. (2002) DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin. Cancer Biol., 12, 389-398.
20. Loukinov, D.I., Pugacheva, E., Vatolin, S., Pack, S.D., Moon, H., Chernukhin, I., Mannan, P., Larsson, E., Kanduri, C., Vostrov, A.A. et al. (2002) BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl Acad. Sci. USA, 99, 6806-6811.
21. Klenova, E., Morse, H., Ohlsson, R. and Lobanenkov, V. (2002) The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin. Cancer Biol., 12, 399-414.
22. van Dijk, M.A., van Schaik, F.M., Bootsma, H.J., Holthuizen, P. and Sussenbach, J. S. (1991) Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol., 81, 81-94.
23. Vu, T.H. and Hoffman, A.R. (1994) Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature, 371, 714-717.
24. Ekstrom, T.J., Cui, H., Li, X. and Ohlsson, R. (1995) Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development, 121, 309-316.
25. Wang, W.H., Duan, J.X., Vu, T.H. and Hoffman, A.R. (1996) Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J. Biol. Chem., 271, 27863-27870.
26. Braczkowski, R., Schally, A.V., Plonowski, A., Varga, J.L., Groot, K., Krupa, M. and Armatis, P. (2002) Inhibition of proliferation in human MNNG/HOS osteosarcoma. and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Cancer, 95, 1735-1745.
27. Thorvaldsen, J.L., Duran, K.L. and Bartolomei, M.S. (1998) Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev., 12, 3693-3702.
28. Ohlsson, R., Hedborg, F., Holmgren, L., Walsh, C. and Ekstrom, T.J. (1994) Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development, 120, 361-368.
29. Steenman, M.J., Rainier, S., Dobry, C.J., Grundy, P., Horon, I.L. and Feinberg, A.P. (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet., 7, 433-439.
30. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T. et al. (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet., 7, 440-447.
31. Taniguchi, T., Sullivan, M.J., Ogawa, O. and Reeve, A.E. (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl Acad. Sci. USA., 92, 2159-2163.
32. Douc-Rasy, S., Barrois, M., Fogel, S., Ahomadegbe, J.C., Stehelin, D., Coll, J. and Rion, G. (1996) High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene, 12, 423-430.
33. Kim, H.T., Choi, B.H., Niikawa, N., Lee, T.S. and Chang, S.I. (1998) Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am. J. Med. Genet., 80, 391-395.
34. el-Naggar, A.K., Lai, S., Tucker, S.A., Clayman, G.L., Goepfert, H., Hong, W.K. and Huff, V. (1999) Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene, 18, 7063-7069.
35. van Gurp, R.J., Oosterhuis, J.W., Kalscheuer, V., Mariman, E.C. and Looijenga, L.H. (1994) Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J. Natl Cancer Inst., 86, 1070-1075.
36. Constancia, M., Dean, W., Lopes, S., Moore, T., Kelsey, G. and Reik, W. (2000) Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat. Genet., 26, 203-206.
37. Eden, S., Constancia, M., Hashimshony, T., Dean, W., Goldstein, B., Johnson, A.C., Keshet, I., Reik, W. and Cedar, H. (2001) An upstream repressor element plays a role in Igf2 imprinting. Embo J., 20, 3518-3525.
38. Jones, B.K., Levorse, J. and Tilghman, S.M. (2001) Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum. Mol. Genet., 10, 807-814.
39. Vu, T.H. and Hoffman, A. (1996) Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor. J. Biol. Chem., 271, 9014-9023.
40. Uejima, H., Lee, M.P., Cui, H. and Feinberg, A.P. (2000) Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat. Genet., 25, 375-376.
41. Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., Molloy, P.L. and Paul, C.L. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA., 89, 1827-1831.
42. Li, T., Vu, T.H., Lee, K.O., Yang, Y., Nguyen, C.V., Bui, H.Q., Zeng, Z.L., Nguyen, B.T., Hu, J.F., Murphy, S.K., Jirtle, R.L. and Hoffman, A.R. (2002) An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoa. J. Biol. Chem., 277, 13518-13527.
43. Xiong, Z. and Laird, P.W. (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucl. Acids Res., 25, 2532-2534.